重组幽门螺杆菌疫苗抗原HpaA培养基的建模与优化。

IF 4.3 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Frontiers in Bioengineering and Biotechnology Pub Date : 2024-12-04 eCollection Date: 2024-01-01 DOI:10.3389/fbioe.2024.1499940
Runqing Tan, Song Zhou, Min Sun, Yu Liu, Xiumei Ni, Jin He, Gang Guo, Kaiyun Liu
{"title":"重组幽门螺杆菌疫苗抗原HpaA培养基的建模与优化。","authors":"Runqing Tan, Song Zhou, Min Sun, Yu Liu, Xiumei Ni, Jin He, Gang Guo, Kaiyun Liu","doi":"10.3389/fbioe.2024.1499940","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong><i>H. pylori</i> (<i>Helicobacter pylori</i>) infection represents a significant global health concern, exacerbated by the emergence of drug-resistant strains resulting from conventional antibiotic treatments. Consequently, the development of vaccines with both preventive and therapeutic properties has become crucial in addressing <i>H. pylori</i> infections. The <i>H. pylori</i> adhesin protein HpaA has demonstrated strong immunogenicity across various adjuvants and dosage forms, positioning it as a key candidate antigen for recombinant subunit vaccines against <i>H. pylori</i>. Optimizing fermentation culture conditions is an effective strategy to enhance product yield and lower production costs. However, to date, there has been no systematic investigation into methods for improving the fermentation yield of HpaA. Enhancing the fermentation medium to increase HpaA yield holds significant potential for application and economic benefits in the prevention and detection of <i>H. pylori</i> infection.</p><p><strong>Methods: </strong>To achieve a stable and high-yielding <i>H. pylori</i> vaccine antigen HpaA, this study constructed recombinant <i>Escherichia coli</i> expressing HpaA. The impact of fermentation medium components on the rHpaA yield was assessed using a one-factor-at-a-time approach alongside Plackett-Burman factorial experiments. Optimal conditions were effectively identified through response surface methodology (RSM) and artificial neural network (ANN) statistical computational models. The antigenicity and immunogenicity of the purified rHpaA were validated through immunization of mice, followed by Western Blot analysis and serum IgG ELISA quantification.</p><p><strong>Results: </strong>Glucose, yeast extract, yeast peptone, NH<sub>4</sub>Cl and CaCl<sub>2</sub> all contributed to the production of rHpaA, with glucose, yeast extract, and NH<sub>4</sub>Cl demonstrating particularly significant effects. The artificial neural network linked genetic algorithm (ANN-GA) model exhibited superior predictive accuracy, achieving a rHpaA yield of 0.61 g/L, which represents a 93.2% increase compared to the initial medium. Animal immunization experiments confirmed that rHpaA possesses good antigenicity and immunogenicity.</p><p><strong>Discussion: </strong>This study pioneers the statistical optimization of culture media to enhance rHpaA production, thereby supporting its large-scale application in <i>H. pylori</i> vaccines. Additionally, it highlights the advantages of the ANN-GA approach in bioprocess optimization.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"12 ","pages":"1499940"},"PeriodicalIF":4.3000,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11652157/pdf/","citationCount":"0","resultStr":"{\"title\":\"Modeling and optimization of culture media for recombinant <i>Helicobacter pylori</i> vaccine antigen HpaA.\",\"authors\":\"Runqing Tan, Song Zhou, Min Sun, Yu Liu, Xiumei Ni, Jin He, Gang Guo, Kaiyun Liu\",\"doi\":\"10.3389/fbioe.2024.1499940\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong><i>H. pylori</i> (<i>Helicobacter pylori</i>) infection represents a significant global health concern, exacerbated by the emergence of drug-resistant strains resulting from conventional antibiotic treatments. Consequently, the development of vaccines with both preventive and therapeutic properties has become crucial in addressing <i>H. pylori</i> infections. The <i>H. pylori</i> adhesin protein HpaA has demonstrated strong immunogenicity across various adjuvants and dosage forms, positioning it as a key candidate antigen for recombinant subunit vaccines against <i>H. pylori</i>. Optimizing fermentation culture conditions is an effective strategy to enhance product yield and lower production costs. However, to date, there has been no systematic investigation into methods for improving the fermentation yield of HpaA. Enhancing the fermentation medium to increase HpaA yield holds significant potential for application and economic benefits in the prevention and detection of <i>H. pylori</i> infection.</p><p><strong>Methods: </strong>To achieve a stable and high-yielding <i>H. pylori</i> vaccine antigen HpaA, this study constructed recombinant <i>Escherichia coli</i> expressing HpaA. The impact of fermentation medium components on the rHpaA yield was assessed using a one-factor-at-a-time approach alongside Plackett-Burman factorial experiments. Optimal conditions were effectively identified through response surface methodology (RSM) and artificial neural network (ANN) statistical computational models. The antigenicity and immunogenicity of the purified rHpaA were validated through immunization of mice, followed by Western Blot analysis and serum IgG ELISA quantification.</p><p><strong>Results: </strong>Glucose, yeast extract, yeast peptone, NH<sub>4</sub>Cl and CaCl<sub>2</sub> all contributed to the production of rHpaA, with glucose, yeast extract, and NH<sub>4</sub>Cl demonstrating particularly significant effects. The artificial neural network linked genetic algorithm (ANN-GA) model exhibited superior predictive accuracy, achieving a rHpaA yield of 0.61 g/L, which represents a 93.2% increase compared to the initial medium. Animal immunization experiments confirmed that rHpaA possesses good antigenicity and immunogenicity.</p><p><strong>Discussion: </strong>This study pioneers the statistical optimization of culture media to enhance rHpaA production, thereby supporting its large-scale application in <i>H. pylori</i> vaccines. Additionally, it highlights the advantages of the ANN-GA approach in bioprocess optimization.</p>\",\"PeriodicalId\":12444,\"journal\":{\"name\":\"Frontiers in Bioengineering and Biotechnology\",\"volume\":\"12 \",\"pages\":\"1499940\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-12-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11652157/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Bioengineering and Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3389/fbioe.2024.1499940\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2024.1499940","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

导言:幽门螺杆菌感染是一个重大的全球健康问题,由于传统抗生素治疗导致的耐药菌株的出现而加剧。因此,开发具有预防和治疗性质的疫苗已成为解决幽门螺杆菌感染的关键。幽门螺杆菌粘附蛋白HpaA在各种佐剂和剂型中显示出很强的免疫原性,使其成为针对幽门螺杆菌的重组亚单位疫苗的关键候选抗原。优化发酵培养条件是提高产品产量和降低生产成本的有效策略。然而,到目前为止,还没有系统的研究方法来提高HpaA的发酵产量。提高发酵培养基中HpaA的产率在幽门螺杆菌感染的预防和检测中具有重要的应用潜力和经济效益。方法:为获得稳定高产的幽门螺杆菌疫苗抗原HpaA,本研究构建了表达HpaA的重组大肠杆菌。采用单因素法和Plackett-Burman析因实验评估发酵培养基组分对rHpaA产量的影响。通过响应面法(RSM)和人工神经网络(ANN)统计计算模型有效地确定了最优条件。通过小鼠免疫验证纯化的rHpaA的抗原性和免疫原性,然后进行Western Blot分析和血清IgG ELISA定量分析。结果:葡萄糖、酵母提取物、酵母蛋白胨、NH4Cl和CaCl2都对rHpaA的产生有贡献,其中葡萄糖、酵母提取物和NH4Cl的作用尤为显著。人工神经网络连接遗传算法(ANN-GA)模型具有较好的预测精度,rHpaA产率为0.61 g/L,比初始培养基提高了93.2%。动物免疫实验证实,rHpaA具有良好的抗原性和免疫原性。讨论:本研究率先对培养基进行统计优化,以提高rHpaA的产量,从而支持其在幽门螺杆菌疫苗中的大规模应用。此外,还强调了ANN-GA方法在生物过程优化中的优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Modeling and optimization of culture media for recombinant Helicobacter pylori vaccine antigen HpaA.

Introduction: H. pylori (Helicobacter pylori) infection represents a significant global health concern, exacerbated by the emergence of drug-resistant strains resulting from conventional antibiotic treatments. Consequently, the development of vaccines with both preventive and therapeutic properties has become crucial in addressing H. pylori infections. The H. pylori adhesin protein HpaA has demonstrated strong immunogenicity across various adjuvants and dosage forms, positioning it as a key candidate antigen for recombinant subunit vaccines against H. pylori. Optimizing fermentation culture conditions is an effective strategy to enhance product yield and lower production costs. However, to date, there has been no systematic investigation into methods for improving the fermentation yield of HpaA. Enhancing the fermentation medium to increase HpaA yield holds significant potential for application and economic benefits in the prevention and detection of H. pylori infection.

Methods: To achieve a stable and high-yielding H. pylori vaccine antigen HpaA, this study constructed recombinant Escherichia coli expressing HpaA. The impact of fermentation medium components on the rHpaA yield was assessed using a one-factor-at-a-time approach alongside Plackett-Burman factorial experiments. Optimal conditions were effectively identified through response surface methodology (RSM) and artificial neural network (ANN) statistical computational models. The antigenicity and immunogenicity of the purified rHpaA were validated through immunization of mice, followed by Western Blot analysis and serum IgG ELISA quantification.

Results: Glucose, yeast extract, yeast peptone, NH4Cl and CaCl2 all contributed to the production of rHpaA, with glucose, yeast extract, and NH4Cl demonstrating particularly significant effects. The artificial neural network linked genetic algorithm (ANN-GA) model exhibited superior predictive accuracy, achieving a rHpaA yield of 0.61 g/L, which represents a 93.2% increase compared to the initial medium. Animal immunization experiments confirmed that rHpaA possesses good antigenicity and immunogenicity.

Discussion: This study pioneers the statistical optimization of culture media to enhance rHpaA production, thereby supporting its large-scale application in H. pylori vaccines. Additionally, it highlights the advantages of the ANN-GA approach in bioprocess optimization.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology Chemical Engineering-Bioengineering
CiteScore
8.30
自引率
5.30%
发文量
2270
审稿时长
12 weeks
期刊介绍: The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信